Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Pharmaceutical Design
|
April 12, 2002
New therapies for the treatment of chronic hepatitis C
G Idéo, A Bellobuono
Environmental Health Perspectives
|
May 1, 1985
Urinary D-glucaric acid excretion in the Seveso area, polluted by tetrachloro-dibenzo-p-dioxin (TCDD): five years of experience
G Idéo, G Bellati, A Bellobuono, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
April 1, 1980
Biochemical and histochemical estimations of liver gamma-glutamyltransferase activity in ethanol-fed rats
G Idéo, S Tempini, A Bellobuono, et al.
European Journal of Gastroenterology & Hepatology
|
February 21, 1998
Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment
A Bellobuono, L Mondazzi, S Tempini, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
September 30, 1980
[Effect of acute administration of high doses of ethanol on the canalicular Na+K+ dependent ATPASE in the isolated and perfused rat liver]
A Bellobuono, G Bellati, S Tempini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 23, 1982
Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD)
G Ideo, G Bellati, A Bellobuono, et al.
Journal of Hepatology
|
October 6, 2000
Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
A Bellobuono, L Mondazzi, S Tempini, et al.
Journal of Viral Hepatitis
|
May 1, 1997
Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial
A Bellobuono, L Mondazzi, S Tempini, et al.
Journal of Hepatology
|
February 2, 1999
Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
A Bellobuono, L Mondazzi, S Tempini, et al.
Clinical and Experimental Rheumatology
|
November 1, 1995
Alpha interferon treatment in chronic hepatitis C
G Idéo, A Bellobuono, L Mondazzi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Pharmaceutical Design
|
April 12, 2002
New therapies for the treatment of chronic hepatitis C
G Idéo, A Bellobuono
Environmental Health Perspectives
|
May 1, 1985
Urinary D-glucaric acid excretion in the Seveso area, polluted by tetrachloro-dibenzo-p-dioxin (TCDD): five years of experience
G Idéo, G Bellati, A Bellobuono, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
April 1, 1980
Biochemical and histochemical estimations of liver gamma-glutamyltransferase activity in ethanol-fed rats
G Idéo, S Tempini, A Bellobuono, et al.
European Journal of Gastroenterology & Hepatology
|
February 21, 1998
Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment
A Bellobuono, L Mondazzi, S Tempini, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
September 30, 1980
[Effect of acute administration of high doses of ethanol on the canalicular Na+K+ dependent ATPASE in the isolated and perfused rat liver]
A Bellobuono, G Bellati, S Tempini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 23, 1982
Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD)
G Ideo, G Bellati, A Bellobuono, et al.
Journal of Hepatology
|
October 6, 2000
Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
A Bellobuono, L Mondazzi, S Tempini, et al.
Journal of Viral Hepatitis
|
May 1, 1997
Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial
A Bellobuono, L Mondazzi, S Tempini, et al.
Journal of Hepatology
|
February 2, 1999
Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
A Bellobuono, L Mondazzi, S Tempini, et al.
Clinical and Experimental Rheumatology
|
November 1, 1995
Alpha interferon treatment in chronic hepatitis C
G Idéo, A Bellobuono, L Mondazzi, et al.
Page
of 2